Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2009
10/27/2009CA2361174C 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
10/24/2009CA2683209A1 Pyrimidinones as casein kinase ii (ck2) modulators
10/22/2009WO2009129508A1 Soluble epoxide hydrolase inhibitors
10/22/2009WO2009127686A1 Novel estrogen receptor ligands
10/22/2009WO2009127546A1 Pyrrolidinone glucokinase activators
10/22/2009WO2009127417A1 Quinoline derivatives as axl kinase inhibitors
10/22/2009WO2009127321A1 Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
10/22/2009US20090264660 Process for alkyl aryl sulfide derivatives and new sulfide compounds
10/22/2009US20090264650 Prophylactic/Therapeutic Agent for Diabetes
10/22/2009US20090264452 2-(Phenylamino)-Pyrimidin-5-Amides As Cannabinoid 2 Receptors Modulators for the Treatment of Immune or Inflammatory Disorders
10/22/2009US20090264451 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264416 N-benzyl,n'-arylcarbonylpiperazine derivatives
10/22/2009US20090264403 Novel azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
10/22/2009US20090263327 Minimally invasive physiological function monitoring agents
10/22/2009CA2721591A1 Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
10/22/2009CA2721371A1 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/22/2009CA2720524A1 Pyrrolidinone glucokinase activators
10/22/2009CA2720215A1 Novel estrogen receptor ligands
10/22/2009CA2718538A1 Quinoline derivatives as axl kinase inhibitors
10/21/2009EP2110374A1 Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
10/21/2009EP2109601A2 Preparation of darifenacin and its salts
10/21/2009EP1515724B1 Mitotic kinesin inhibitors
10/21/2009EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
10/21/2009EP1463506B1 Substituted quinazoline derivatives as inhibitors of aurora kinases
10/21/2009EP1448526B1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
10/21/2009EP1426365B9 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
10/21/2009EP1381366B9 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/21/2009CN101563338A MAPK/ERK kinase inhibitors
10/21/2009CN101563319A Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
10/21/2009CN101560207A Preparation method of paroxetine hydrochloride and intermediate thereof
10/21/2009CN101560206A Intermediate of pemetrexed disodium, preparation method thereof and method for preparing pemetrexed disodium thereby
10/21/2009CN101560205A Preparation method of difenoconazole technical material
10/21/2009CN101560191A Alpha-menaphthyl substituted spiro bis(oxazoline) ligands, synthetic method and application thereof in synthesizing pyrazolidine derivatives
10/21/2009CN101559053A 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
10/20/2009US7605277 N,N'-Di(1-naphthyl)-N,N'-diphenyl-2,6-diaminodibenzodioxin; organic electroelement hole-transporting layer, light-emitting material, a host materialor dopant in the light-emitting layer,a hole-blocking layer, an electron-transporting layer;high luminous efficiency; high heat resistance; durability
10/20/2009US7605273 P38 map kinase inhibitors; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure
10/20/2009US7605168 PDE4B inhibitors
10/20/2009US7605165 Phenylalanine derivatives
10/20/2009US7605162 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; high affinity for both the dopamine D2 receptor and the serotonin reuptake site; nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia
10/20/2009US7605159 Cathepsin cysteine protease inhibitors and their use
10/20/2009US7605158 Carbamoyl-type benzofuran derivatives
10/20/2009US7604815 Insecticidal N-substituted (heteroaryl)cycloalkyl sulfoximines
10/20/2009CA2434408C Process for the preparation of heterocyclic indene analogs
10/20/2009CA2407371C Quinazoline derivatives for the treatment of tumours
10/20/2009CA2368993C C7 ester substituted taxanes as antitumor agents
10/20/2009CA2214793C Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
10/20/2009CA2168937C Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines
10/15/2009WO2009125853A1 Homocysteine synthase inhibitor
10/15/2009WO2009125841A1 Process for production of ethynylthymidine compound using 5-methyluridine as starting raw material
10/15/2009WO2009125597A1 Acylthiourea compound or salt thereof, and use of the compound or the salt
10/15/2009WO2009125434A2 Oxime derivatives
10/15/2009WO2009125430A2 Improved process for producing darifenacin
10/15/2009WO2009125426A2 NOVEL PROCESS FOR THE PREPARATION OF (3SM-[2-(2 J-DIHYDRO-5- BENZOFURANYLϊETHYL]-α.α -DIPHENYL-3-PYRROLIDINEACETAMIDE HYDROBROMIDE
10/15/2009WO2009124968A1 Novel estrogen receptor ligands
10/15/2009WO2009124882A1 Novel piperidinyl-1,3-dihydro-benzoimidazol-2-ones as m1 agonists
10/15/2009WO2009124638A1 Glucopyranoside derivatives
10/15/2009WO2009085344A3 Dibenzothiophene, dibenzofuran and/or carbazole-containing materials in phosphorescent light emitting diodes
10/15/2009US20090259048 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
10/15/2009US20090258910 benzo[1,3]dioxol-5-yl-carbamic acid 6-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)-naphthalen-2-yl ester and benzo[1,3]dioxol-5-yl-carbamic acid 8-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)-naphthalen-2-yl ester;
10/15/2009US20090258904 Epithiolone Analogues
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
10/15/2009US20090258881 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
10/15/2009US20090258876 Novel indol carboxylic acid bispyridyl carboxamide derivatives, pharmaceutically acceptable salt thereof, preparation method and composition containing the same as an active ingredient
10/15/2009US20090258016 Substituted imidazole derivatives
10/15/2009US20090257953 Novel fluorine-18 labeled rhodamine derivatives for myocardial perfusion imaging with positron emission tomography
10/15/2009CA2725425A1 Homocysteine synthase inhibitor
10/15/2009CA2720586A1 Glucopyranoside derivatives
10/15/2009CA2720552A1 Acylthiourea compound or salt thereof, and use thereof
10/14/2009EP2108012A2 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
10/14/2009EP1856082B1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
10/14/2009EP1594858B1 Novel benzoimidazole derivatives useful as antiproliferative agents
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009CN101558063A Compositions of azimilide dihydrochloride
10/14/2009CN101558062A Indolylmaleimide derivatives as kinase inhibitors
10/14/2009CN101555230A Synthesizing method of aromatic ring ureas loop-coil medicament template
10/14/2009CN101554409A Long pepper alkaloid and preparation method, preparation and application thereof
10/14/2009CN100548992C Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
10/14/2009CN100548985C N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B
10/14/2009CN100548980C Isoindoline derivative
10/14/2009CN100548978C Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors
10/14/2009CN100548294C Use of compound in preparing medicine for enhancement of bone growth and inhibition of bone resorption
10/13/2009US7601843 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching
10/13/2009US7601742 Pyrrolidones with anti-HIV activity
10/13/2009US7601730 Carboxylic acid derivatives, their preparation and use
10/13/2009US7601729 Matrix metalloproteinase inhibitors
10/13/2009US7601702 Dutpase Inhibitors
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/13/2009CA2429844C Mch antagonists and their use in the treatment of obesity
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/13/2009CA2368274C C10 ester substituted taxanes as antitumor agents
10/13/2009CA2355098C Chroman derivatives
10/13/2009CA2341678C Potassium channel inhibitors and method
10/13/2009CA2292775C Cyanoguanidines as cell proliferation inhibitors
10/08/2009WO2009123896A1 Pyridyl derivatives as cftr modulators
10/08/2009WO2009123870A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009123080A1 Indolinone compound
10/08/2009WO2009122707A1 1,3-dihydroisobenzofuran derivative
10/08/2009WO2009122447A1 Semi-synthetic sesquiterpene lactone parthenin compound useful for cytotoxicity against cancer cell lines and anticander agent
10/08/2009WO2009121910A1 Indene derivatives as estrogen receptor ligands
1 ... 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 ... 694